The market accounted for a market value of USD 15.65 million in 2015. The market is projected to reach a value of USD 33.83 million in 2021, growing at a CAGR of 16.66%. Optogenetics is the combination of genetics and optics to control well-defined events within specific cells of tissues.
It includes the discovery and insertion into cells of genes that confer light responsiveness and also includes the associated technologies for delivering light, deep into organisms as complex as freely moving animals, for targeting light sensitivity of cells of interest and for assessing specific readouts or effects of this optical control. Optogenetics is a tool that is trending in the research fields of neuroscience, behavioral science, ophthalmology, cardiology and other healthcare domains.
Global optogenetic market is segmented based on the light equipment used, actuators, and sensors. The light equipment market is further segmented into lasers, LEDs and others. The optogenetic actuators are segmented further into in the types available like Channelrhodopsin, Halorhodopsin, Archaerhodopsin and others. The optogenetic sensor market is also segmented based on the type, into calcium sensors (Aequorin, Cameleon, GCaMP), chloride (Clomeleon), membrane gated (Mermaid) and others. The optogenetics market segmentation also includes categories based on application and species. The segmentation based on applications have been subdivided into neuroscience, behavioral tracking, retinal disease treatment, correction of hearing impairment, cardiovascular ailments and pacing. The global optogenetic market based on geography is segmented into North America (USA and Canada) Europe (UK, Spain, Germany, Italy, others), Asia-Pacific (India, China, Australia, Japan and others) and ‘Rest of the World’.
Global optogenetics market is driven by various factors like the growing use of this tool in the field of neuroscience and behavioral science, the potential rapid growth of technology like ultrafast laser tools, LEDs, ytterbium-based lasers and others, and the increasing number of labs worldwide that have adopted the technology for research.
The market is restrained by factors like high cost of technology, lack of awareness of the tools in developing countries, reluctance in adoption of new technology by healthcare professionals and the nascent stage of the technology that the market has yet to mature in.
The key players in the optogenetics market are Coherent Inc., Thorlabs Inc. Cobalt Inc., Scientifica, Laserglow technologies, Regenxbio Inc., Addgene, UPenn Vector Core and Jackson Laboratories., among others.
Specialities Of This Report
What the Report Offers